Pharma firm Teva to divest its business venture in Japan
(Reuters) – Teva Pharmaceutical Industries said on Thursday it will transfer ownership of its business venture that sold generics in Japan to JKI. Israel-based Teva’s deal with JKI will transfer all the shares of the unit Teva-Takeda and its subsidiary Teva Takeda Yakuhin to the firm. Teva-Takeda is a joint venture established in 2016 by …
Pharma firm Teva to divest its business venture in Japan Read More »